VPS9D1 and prostate cancer: For example, it was reported that VPS9D1-AS1 can upregulate the expression of myocyte enhancer factor 2D through competitively sponging miRNA-4739, thus promoting the malignant progression of prostate cancer (Wang et al., 2020).